Home DUSA Pharmaceuticals

DUSA Pharmaceuticals

Out of service
-
Drug Developer
Basic
Enterprise Profile

Basic Information

DUSA Pharmaceuticals is a fully integrated specialty pharmaceutical company primarily focused on developing and marketing its Levulan® photodynamic therapy (PDT) technology platform, which is used in conjunction with its proprietary light source, the BLU-U® blue light photodynamic therapy illuminator. Levulan Kerastick® (aminolevulinic acid hydrochloride) for Topical Solution, 20%, in combination with BLU-U, is approved by the U.S. Food and Drug Administration for the treatment of mild to moderate actinic keratosis (AK) on the face or scalp.
DUSA Pharmaceuticals, Inc.
Massachusetts,United States of America
51~100 people
November 01, 2012
--
customerservice@dusapharma.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Biotechnology
Concept
Dermatology Department Support Departments Disease Treatment
Application Scenarios
Chemical Drug Innovative Drugs